- Thinly traded nano cap Realm Therapeutics (NASDAQ:RLM +9.6%) is up, albeit on only 3,300 shares, following its announcement that shareholders have voted in favor of its proposed asset disposal to Urgo, U.S. The transaction should close on March 28.
- Shares will also be delisted from London stock exchange (AIM) on March 27.
- The company imploded after lead candidate PR022 failed to beat placebo in a mid-stage eczema study.